Dr. Scott Treiber, PhD, MBA
Dr. Scott Treiber, Ph.D., MBA, is the Chief Development Officer at Elligo Health Research. Before his current role, he was the Executive Vice President, Biopharmaceutical Development and GM at Chiltern. He is an experienced professional with over 20 years of increasing responsibility in the biopharmaceutical and device industry. Dr. Treiber has expertise in clinical operations, clinical development, medical affairs, data management/statistics, pharmacovigilance/safety and medical writing. He also has broad therapeutic expertise in CNS, oncology, hematology, pain, cardiovascular, renal, anti-infectives, and respiratory. Dr. Treiber also has experience with managed budgets (>$100M), resources, metrics and quality systems. His prior roles include Senior Vice President & General Manager, Neuroscience at inVentiv Health Clinical; and VP, Global Clinical Operations & Medical Affairs at Hospira.